NB
Nimit Bansal
About Nimit Bansal
Data last updated:
Nimit Bansal is an Additional Director at Rapross Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Rapross Pharmaceuticals Private Limited reported revenue of ₹29.39 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rapross Pharmaceuticals Private Limited U74899DL1995PTC066606 | Additional Director | 01 Sep 2023 | 1995 | ₹29.39 Cr (FY 2023) | Active |
Board colleagues of Nimit Bansal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Parveen Kumar Bansal | 07550240 | Rapross Pharmaceuticals Private Limited | Director |
| Ranjan Verma | 00180751 | Rapross Pharmaceuticals Private Limited | Director |
| Shailendra Singh | 11220945 | Rapross Pharmaceuticals Private Limited | Additional Director |
| Sharad Verma | 10311241 | Rapross Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nimit Bansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nimit Bansal
Nimit Bansal currently holds 1 directorship: Rapross Pharmaceuticals Private Limited (Additional Director, since 01 Sep 2023, revenue ₹29.39 Cr (FY 2023)).
Nimit Bansal was first appointed on 01 Sep 2023 as Additional Director at Rapross Pharmaceuticals Private Limited.
The current boards of Nimit Bansal's companies include Parveen Kumar Bansal (Rapross Pharmaceuticals Private Limited), Ranjan Verma (Rapross Pharmaceuticals Private Limited), Shailendra Singh (Rapross Pharmaceuticals Private Limited), Sharad Verma (Rapross Pharmaceuticals Private Limited).